Symptomatic edema
Self-prescribed diuretics for edema without an established cause are not supported by clinical guidelines. Edema in cardiac, renal, hepatic failure, or venous disease is treated by addressing the underlying condition.
ICD-10 R60.94 drugs
Drugs used for this condition
Marketing claims without evidence base
The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.
- FAzilsartan medoxomil + chlorthalidoneNot recommended · Fixed-dose combination: angiotensin II receptor blocker with a thiazide-like diureticThe combination is sometimes taken for swelling, because a diuretic sits inside and the tablet is already in the cabinet. The FDA Edarbyclor label knows one indication, hypertension, and carries nothing about oedema. Leg swelling comes from venous insufficiency, from calcium channel blockers, from low albumin, from heart or kidney failure, and a diuretic helps in only some of those while it simply dehydrates in the rest. The risk is concrete: chlorthalidone drops sodium and potassium, and in an older person hyponatraemia unfolds as confusion, nausea or a fall rather than thirst. The sartan beside it adds a fall in renal filtration once the person is dehydrated. If a sartan combination was prescribed to treat swelling, consider seeking a second opinion.
- FFurosemideNot recommended · Loop diureticsSelf-medication with furosemide for «morning puffiness», «edema from fatigue», and similar complaints without an established clinical diagnosis is unsafe and unsupported by guidelines. Regular use without an indication causes hypokalemia, hyponatremia, dehydration, rebound fluid retention on withdrawal, and diuretic-associated nephropathy. Edema warrants a differential workup: cardiac, renal, hepatic, venous, lymphatic, or drug-induced. Diuretics are started after a cause is established.
- FProteolytic enzyme complex (bromelain, papain, pancreatin, trypsin, chymotrypsin, rutoside)Not recommended · Combined enzyme preparations, systemic enzyme therapy (local classification)For non-clinical complaints of facial and lower-limb oedema, wobenzym is prescribed as an «anti-oedema» agent. Independent RCTs with objective oedema measurement endpoints do not exist. Evidence-based approach to confirmed oedema: differential diagnosis of the cause (heart failure, nephrotic syndrome, venous insufficiency, lymphoedema), then aetiotropic therapy.
How to read tiers A–F
Evidence tiers belong to the drug-indication pair, not to the drug as a whole: the same substance can be A for one condition and F for another.
- AStrong evidence – first or second line in international guidelines
- BRecommended in selected cases
- CStudy data contradict each other
- DBenefit not proven, no documented harm
- FDocumented harm, or risk without benefit